Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Abiraterone on Oxycodone Metabolism in Prostate Cancer
NCT07001709Phase 4Recruiting
- Sponsor
- Deventer Ziekenhuis
- Start
- Apr 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of abiraterone in prostate cancer (PCa), sponsored by Deventer Ziekenhuis. Started Apr 2024; status: recruiting.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07001709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07001709.